These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38259473)

  • 21. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
    Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
    Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
    Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome.
    Sato W; Ono H; Matsutani T; Nakamura M; Shin I; Amano K; Suzuki R; Yamamura T
    Brain Behav Immun; 2021 Jul; 95():245-255. PubMed ID: 33794313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Johnston S; Staines D; Klein A; Marshall-Gradisnik S
    BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?
    Kavyani B; Lidbury BA; Schloeffel R; Fisher PR; Missailidis D; Annesley SJ; Dehhaghi M; Heng B; Guillemin GJ
    Cell Mol Life Sci; 2022 Jul; 79(8):412. PubMed ID: 35821534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of mast cell toll-like receptor 3 in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Systemic Mastocytosis using the novel application of autoMACS magnetic separation and flow cytometry.
    Balinas C; Nguyen T; Johnston S; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2018 Dec; 36(4):257-264. PubMed ID: 29223146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
    J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
    Querec TD; Lin JS; Chen Y; Helton B; Kogelnik AM; Klimas NG; Peterson DL; Bateman L; Lapp C; Podell RN; Natelson BH; Unger ER;
    J Transl Med; 2023 Apr; 21(1):242. PubMed ID: 37013608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    Front Immunol; 2019; 10():2545. PubMed ID: 31736966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.